Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 ...
China’s government wants to strengthen domestic consumption, encourage family formation, increase fertility and achieve more ...
Ecopipam, Emalex's investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late- ...
2h
OPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first ...
While Magnificent Seven drove equity index returns in recent years, earnings growth has been broadening beyond mega-cap tech ...
Lemonade, Inc. ( LMND) Q1 2026 Earnings Call April 29, 2026 8:00 AM EDT Hello, everyone. Thank you for joining us and welcome to Lemonade's Q1 2026 Earnings Call. I will now hand the conference over ...
An affidavit said Soza-Fraire would upload images of 16 and 17-year-old former classmates, and the AI program would make ...
Activism – from the 1831 riots and the 1963 Bus Boycott to the toppling of Colston’s statue – has always been the lifeblood systemic change in this city,” said Julz Davis, disruptor-in-chief at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results